ARCHER TIMOTHY, President and CEO, has demonstrated a pronounced selling bias in his recent insider trading activity, as evidenced by SEC Form 4 filings. Over the course of 35 transactions involving two companies—Johnson Controls International (JCI) and Lam Research Corporation (LRCX)—Archer has sold shares totaling $88.66 million while purchasing shares worth just $4 million. This pattern underscores a clear preference for divestment over accumulation. Notably, his most significant sales have been concentrated in LRCX, with multiple high-value transactions occurring in late February 2026, including a single sale of $31.49 million on February 27, 2026, and earlier sales of $18.57 million and $8.19 million on December 17, 2025. These transactions dwarf his smaller purchases, such as the $765,097.80 and $642,620.76 acquisitions of LRCX shares on February 28, 2025.
Archer’s activity in JCI has been comparatively limited, with only a few transactions, including a sale of $156,100 on March 4, 2026, and a smaller sale of $111,410.88 on March 12, 2025. His recent trades, all of which are sales, further emphasize this divestment trend. The absence of any recent purchases suggests a continued focus on reducing his holdings in both companies. While the reasons behind these transactions remain undisclosed, the data paints a clear picture of Archer’s trading behavior: a consistent and substantial reduction in his equity positions across LRCX and JCI.
AI-assisted summary